Disc Medicine to present initial Phase 2 RESTORE-PV data for DISC-3405 in polycythemia vera at SOHO 2026
IRON•Phase 2 RESTORE-PV data slated for SOHO 2026
Disc Medicine flagged initial Phase 2 RESTORE-PV data for DISC-3405 in polycythemia vera for presentation at SOHO 2026.
Results have not been presented yet; an oral update is scheduled for Sept. 10, 2026, with a poster on Sept. 9.
Planned disclosure covers baseline and safety from 40 patients, with pharmacology and early efficacy readouts from the first 20.
Additional Phase 2 update planned for DISC-0974
The company also plans to present initial Phase 2 RALLY-MF efficacy findings for DISC-0974 to treat anemia in myelofibrosis.
